Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children

Polat M., Kara S. S. , Tapisiz A., Tezer H., Kalkan G., Dolgun A.

PEDIATRIC DRUGS, vol.17, no.4, pp.323-330, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 17 Issue: 4
  • Publication Date: 2015
  • Doi Number: 10.1007/s40272-015-0133-5
  • Journal Name: PEDIATRIC DRUGS
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.323-330

Abstract

Objective The objective of this study was to compare the safety and efficacy of inhaled plus intravenous (IV) colistin with that of IV colistin alone in critically ill children with ventilator-associated pneumonia (VAP) due to colistin-only susceptible (COS) Gram-negative bacteria (GNB).